A Retrospective Study Assessing Acute Tolerability Of The Gadolinium-Based Contrast Agents (GBCAs) In Clinical Practice.

Trial Profile

A Retrospective Study Assessing Acute Tolerability Of The Gadolinium-Based Contrast Agents (GBCAs) In Clinical Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Gadobenic acid (Primary) ; Gadobutrol (Primary) ; Gadopentetic acid (Primary) ; Gadoterate-meglumine (Primary) ; Gadoxetate disodium (Primary)
  • Indications Biliary tract disorders; Bladder disorders; Brain disorders; Breast cancer; Colorectal cancer; Head and neck cancer; Liver disorders; Ovarian cancer; Pancreatic disorders; Rectal cancer; Renal cancer; Sarcoma; Tumours; Uterine cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top